Lindbrook Capital, LLC Axsome Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 64,707 shares of AXSM stock, worth $6.89 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

64,707

Previous 70,326 7.99%

Holding current value

$6.89 Million

Previous $5.66 Million 2.69%

% of portfolio

0.49%

Previous 0.54%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$78.93 - $95.84 $443,507 - $538,524	-5,619 Reduced 7.99%	64,707 $5.81 Million
Q2 2024 Jul 31, 2024	SELL	$65.72 - $80.5 $883,408 - $1.08 Million	-13,442 Reduced 16.05%	70,326 $5.66 Million
Q1 2024 Apr 25, 2024	SELL	$69.39 - $97.64 $22,066 - $31,049	-318 Reduced 0.38%	83,768 $6.68 Million
Q4 2023 Jan 31, 2024	SELL	$57.42 - $83.61 $13,378 - $19,481	-233 Reduced 0.28%	84,086 $6.69 Million
Q3 2023 Oct 25, 2023	SELL	$69.25 - $82.21 $10,387 - $12,331	-150 Reduced 0.18%	84,319 $5.89 Million
Q2 2023 Jul 28, 2023	BUY	$58.41 - $90.35 $14,485 - $22,406	248 Added 0.29%	84,469 $6.07 Million
Q1 2023 Apr 26, 2023	SELL	$58.39 - $75.0 $19,210 - $24,675	-329 Reduced 0.39%	84,221 $5.19 Million
Q4 2022 Jan 24, 2023	BUY	$39.94 - $79.72 $3.37 Million - $6.74 Million	84,498 Added 162496.16%	84,550 $0
Q3 2022 Nov 10, 2022	BUY	$36.06 - $69.85 $1,550 - $3,003	43 Added 477.78%	52 $2,000
Q2 2022 Aug 01, 2022	SELL	$21.74 - $46.75 $2,913 - $6,264	-134 Reduced 93.71%	9 $0
Q1 2022 Apr 21, 2022	SELL	$23.7 - $41.39 $165 - $289	-7 Reduced 4.67%	143 $6,000
Q4 2021 Jan 18, 2022	SELL	$30.7 - $43.36 $7,675 - $10,840	-250 Reduced 62.5%	150 $6,000
Q3 2021 Nov 05, 2021	SELL	$19.91 - $68.26 $9,955 - $34,130	-500 Reduced 55.56%	400 $13,000
Q4 2020 Jan 27, 2021	BUY	$66.31 - $86.52 $13,262 - $17,304	200 Added 28.57%	900 $73,000
Q3 2020 Nov 03, 2020	BUY	$68.34 - $85.84 $47,838 - $60,088	700 New	700 $50,000
Q2 2020 Jul 27, 2020	SELL	$49.87 - $98.69 $3,790 - $7,500	-76 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$41.2 - $101.31 $13,348 - $32,824	-324 Reduced 81.0%	76 $4,000
Q4 2019 Jan 27, 2020	BUY	$16.71 - $106.24 $6,684 - $42,496	400 New	400 $41,000
Q3 2019 Oct 31, 2019	SELL	$20.24 - $29.16 $8,095 - $11,664	-400 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$13.46 - $25.75 $5,384 - $10,300	400 New	400 $10,000

Others Institutions Holding AXSM

# of Institutions

327

Shares Held

38M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Axsome Therapeutics, Inc. Transaction History